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Previous studies show that a 10% cocoa diet, containing polyphenols and fibre among others, 21 
modifies intestinal and systemic immunoglobulin (Ig) production. The present study was aimed at 22 
evaluating the impact of cocoa on IgA and IgM production in the intestinal and extra-intestinal 23 
mucosal compartments, establishing the involvement of cocoa fibre in such effects. Mechanisms by 24 
which cocoa intake may affect the IgA synthesis in the salivary glands were also studied. To this 25 
effect, rats were fed either a standard diet, a diet containing cocoa (C10), cocoa fibre (CF) or inulin 26 
(I). Intestinal (the gut wash (GW), Peyer’s patches (PP) and mesenteric lymph nodes (MLN)) and 27 
extra-intestinal (salivary glands) mucosal tissues and blood samples were collected for IgA and IgM 28 
quantification. The IgA production- and homing-related molecules gene expression was studied in 29 
the salivary glands. The C10 diet decreased IgA and IgM intestinal production. Although CF diet 30 
decreased the GW IgA concentration, it increased PP, MLN and serum IgA concentration. Both the 31 
C10 and the CF diets produced a down-regulatory effect on the IgA secretion in the extra-intestinal 32 
tissues. The C10 diet interacted with the mechanisms involved in the IgA synthesis, whereas the CF 33 
showed particular effects on the homing and transcytosis of IgA across the salivary glands. Overall, 34 
CF is able to up-regulate IgA production in the intestinal-inductor compartments whereas it down-35 
regulates its production at the mucosal-effector ones. Further studies must be directed to ascertain 36 
the mechanisms involved in the effect of particular cocoa components on gut-associated lymphoid 37 







The gut-associated lymphoid tissue (GALT) is the first line of defence against a variety of antigens 43 
(Ag) in the intestine. Structurally, the GALT is divided into organized and diffuse compartments. 44 
The organized or inductor GALT is formed by isolated lymphoid follicles (ILF) and Peyer’s patches 45 
(PP), whereas the diffuse or effector GALT is formed by lymphocyte populations scattered across 46 
the epithelial or in the lamina propria. Moreover, the mesenteric lymph nodes (MLN) are part of the 47 
intestinal immune system, although they are not referred to as GALT as they do not sample 48 
intestinal antigens directly(1). 49 
The main humoral immune product in the GALT, as well as in the other mucosal tissues, is the 50 
polymeric immunoglobulin (Ig) A (IgA), which represents around 80-90% of the total secreted Ig 51 
(S-Ig) of the body(2,3). In a lower proportion, IgM (6-19%) and IgG (4-5%) are also present in the 52 
mucosal surfaces(4). The high content of S-IgA in the intestine plays a key role in the maintenance 53 
of gut homeostasis and oral tolerance(5). 54 
M cells from PP are specialized cells in luminal Ag uptake that transport luminal Ags from the 55 
intestinal lumen towards Ag-presenting cells. These cells interact with interfollicular T 56 
lymphocytes(5), which once activated bring about the differentiation and maturation of B cells, 57 
inducing them to become IgA+ cells and later IgA-secreting cells (IgA-SCs). This process depends 58 
on determined cytokines, such as transforming growth factor β1 (TGF-β1), interleukin (IL)-5, IL-6, 59 
IL-10 and IL-21(6–9). B-cell differentiation occurs in PP and, to a lesser extent, in ILF and MLN(2). 60 
From those inductive sites, the activated B cells reach peripheral blood and migrate to secretory 61 
effector sites where they extravasate depending on adhesion molecules and chemokine-chemokine 62 
receptor pairs(1,10). The interaction between several regulated endothelial adhesion molecules and 63 
the corresponding ligands expressed on the memory/effector B cells’ surface provokes a successful 64 
homing.  65 
Although GALT is thought to constitute the major part of mucosal-associated lymphoid tissue 66 
(MALT), the induction of mucosal immune responses can take place in other mucosal 67 
compartments that also belong to the MALT(3). In fact, studies point to the possibility that other 68 
mucosal compartments may be even more important than the GALT ones for S-IgA production. In 69 
this sense, salivary glands are considered important effector sites in the mucosal immune 70 
network(11).  71 
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Previous studies carried out in our laboratory have demonstrated the ability of a cocoa diet to 72 
modulate the immune system in vitro and in vivo(12). In particular, a down-regulation of the serum 73 
and intestinal Ig content was observed in young rats fed with a cocoa diet(13–16). As cocoa contains 74 
mainly flavonoids such as (−)-epicatechin, (+)-catechin and their polymeric forms called 75 
procyanidins(17), most of these effects of cocoa have been attributed to its high content of 76 
polyphenols(18). However, it must be added that cocoa is also an important source of dietary fibre 77 
(DF) (26-40% of its content, mostly insoluble fibre) and, therefore, DF seems to strengthen or to be 78 
in part responsible for the effects described above(19). 79 
On the basis of this background, the aim of this study was to investigate in depth the impact of 80 
cocoa on IgA and IgM production in the intestinal and extra-intestinal (salivary glands) mucosal 81 
compartments, establishing the particular involvement of cocoa fibre in such effects. Moreover, 82 
some of the mechanisms by which cocoa intake may affect the expression of molecules involved in 83 
IgA+ B cell homing and IgA synthesis in the salivary glands were also studied.  84 
Material and Methods 85 
Animals and diets 86 
Female Wistar rats (3-week-old) were obtained from Janvier Labs (Saint-Berthevin, France) and 87 
housed in cages under conditions of controlled temperature and humidity in a 12:12 light-dark 88 
cycle. The rats were randomly distributed into four dietary groups: the reference (REF), cocoa 89 
(C10), cocoa fibre (CF) and inulin (I) groups (n=10/each group). The REF group was fed with the 90 
standard diet AIN-93M (Harlan, Barcelona, Spain); the C10 group received chow containing 10% 91 
cocoa, which finally provided 0.4% of polyphenols, 0.85% soluble fibre and 2.55% of insoluble 92 
fibre; the CF group received a diet with the same proportions of soluble and insoluble cocoa fibre as 93 
the C10 group but with a very low amount of polyphenols (<0.02%); and the I group received the 94 
AIN-93M standard diet, to which the same amount of soluble fibre as that given to the C10 group 95 
(0.85%) was added, but as inulin, in order to distinguish the particular effect of soluble cocoa fibre 96 
(Table 1). Natural Forastero cocoa and cocoa fibre powders (provided by Idilia Foods S.L. 97 
(formerly Nutrexpa S.L.), Barcelona, Spain) with 4.02% and 0.35% of polyphenols, respectively, 98 
were used to elaborate the C10 and CF diets. Inulin from chicory roots (Fibruline® Instant; 99 
InnovaFood 2005, S.L., Barcelona, Spain) was used as a reference soluble fibre. The three 100 
experimental diets were elaborated on the basis of the AIN-93M formula by subtracting the amount 101 
of carbohydrates, proteins, lipids and insoluble fibre provided by the corresponding supplements.  102 
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Casein 121.5 97.1 109.7 118.7 
L-Cystine 1.8 1.4 1.4 1.6 
Corn Starch 418.1 423.7 437.2 426.4 
Maltodextrin 148.5 118.7 120.4 131.5 
Sucrose 102.6 108.7 110.9 110.9 
Soybean oil 38.2 26.2 33.5 38.9 
Cellulose 50 24.5 26.5 50.0 
Minerals 35.3 27.7 27.9 31.3 
Vitamins 9.1 7.2 7.2 8.1 
Choline bitartrate 2.5 2.0 2.0 2.2 
tert-Butylhydroquine 0.008 0.006 0.006 0.006 
Water 72.4 63 71.1 72 
Extract - 100 52.3              8.5 
    
        Protein            - 22    8      - 
        Carbohydrate            - 16    0.5      - 
        Lipid            - 11    4.8      - 
        Fibre (insoluble/soluble)            - 34 (25.5/8.5)  31.9 (23.4/8.5)    8.5 (- /8.5) 
 Minerals            - 6         7      - 
        Total Polyphenols
1
            - 4         0.2      - 
        Water 
 




      - 
 
     - 
 
     
1
 Total polyphenol compounds were quantified using the Folin-Ciocalteu method.  
 
The resulting chows were isoenergetic and had a similar proportion of macronutrients 103 
(carbohydrates, proteins and lipids) and insoluble fibre as the reference diet (Table 1). Animals 104 
were given free access to water and chow. The diets lasted for three weeks. In addition, taking into 105 
account the obtained results, a similar design but with just one week of diet duration was executed 106 
which results are included as a supplementary material.  107 
Studies were performed according to the criteria outlined by the Guide for the Care and Use of 108 
Laboratory Animals. Experimental procedures were reviewed and approved by the Ethical 109 
Committee for Animal Experimentation of the University of Barcelona (ref. 358/12). 110 
Sample collection and preparation 111 
At the end of the nutritional intervention, mucosal and blood samples were collected for Ig 112 
quantification. Briefly, animals were anaesthetized intramuscularly with ketamine (90 mg/kg) 113 
(Merial Laboratorios, S.A., Barcelona, Spain) and xylazine (10 mg/kg) (Bayer A.G, Leverkusen, 114 
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Germany). The small intestine, mesenteric lymph nodes (MLN), and the left submaxillary salivary 115 
gland (SMG) and the left parotid salivary gland (PSG) were collected. A small piece of SMG was 116 
immediately immersed in RNAlater® (Ambion, Life Technologies, Austin, TX, USA), incubated at 117 
4 ºC overnight and stored at -20 ºC until PCR analysis. The distal half of the small intestine was 118 
carefully rinsed with cold 0.9% NaCl saline solution in order to remove faecal content, it was 119 
opened lengthwise and visible Peyer’s patches (PP) were excised. The intestinal tissue without PP 120 
was used to obtain the gut wash (GW) for Ig quantification by ELISA, as established previously in 121 
our laboratory(13). The MLN, PP and both salivary glands were processed for Ig quantification. For 122 
this purpose, MLN, PP, SMG and PSG homogenates were obtained as described previously(16).  123 
Immunoglobulin quantification 124 
IgA and IgM concentrations in GW, MLN, PP, SMG and PSG homogenates and serum IgA, IgM 125 
and IgG were quantified at the end of the nutritional intervention by ELISA following the 126 
manufacturer’s instructions for IgA (Bethyl Laboratories, Inc., Montgomery, TX, USA) and IgM 127 
(BD Biosciences, Heidelberg, Germany). Absorbance was measured in a microplate photometer 128 
(LabSystems Multiskan) and data were interpolated using ASCENT version 2.6 software (Thermo 129 
Fisher Scientific) into the standard curves, and expressed as ng/mg of tissue in homogenates and 130 
GW, and as µg/mL for the serum results. 131 
Assessment of RNA gene expression by RT-PCR 132 
To assess the gene expression of IgA, TGF-β1, RARα, RARβ, CCL28, pIgR and IL-6, the RNA 133 
was isolated from SMG samples by the RNeasy® Mini Kit (Qiagen, Madrid, Spain) following the 134 
manufacturer’s recommendations. The NanoDrop spectrophotometer and NanoDrop IVD-1000 135 
V.3.1.2 software (NanoDrop Technologies, Wilmington, DE, USA) were used to quantify the 136 
amount of RNA obtained. The Agilent 2100 Bioanalyzer with the RNA 6000 LabChip 1 kit 137 
(Agilent Technologies, Madrid, Spain) was used to assess the RNA integrity for each sample. All 138 
samples used for further experiments showed an RNA integrity number (RIN) ≥ 9 and purity 139 
between 1.814 and 2.033 using the A260/A280 ratio. Two μg of total RNA was converted to cDNA. 140 
Specific PCR TaqMan® primers and probes (Applied Biosystems, AB, Weiterstadt, Germany) were 141 
used to measure selected targets: Iga (331943, made to order), Ccl28 (Rn00586715_m1, I), Tgfb1 142 
(Rn00572010_m1, I), Rara (Rn00580551_m1, inventoried (I)), Rarb (Rn01537835_m1, I), Pigr 143 
(Rn00562362_m1, I) and Il6 (Rn01410330_m1, I). Quantitative real-time PCR assays were 144 
performed in duplicate for each sample using an ABI PRISM 7900HT Sequence Detection System 145 
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(AB). Quantification of the studied genes was normalized to the housekeeping Gusb (beta 146 
glucuronidase gene) (Rn00566655_m1, I), which showed constant level of expression in our 147 
experimental conditions being similar to the level of expression of studied genes. The SDS v2.4 148 
software (AB) was used to analyse the expression data. The amount of target mRNA relative to the 149 
endogenous control expression was calculated for the three nutritional intervention groups relative 150 
to values from the REF group, which represents 100% gene expression, using the standard 2-∆∆Ct 151 
method, as previously described(20). Results are expressed as the mean ± SEM of the percentage of 152 
these values. 153 
Statistical analysis 154 
Levene’s and Kolmogorov–Smirnov tests were applied to assess variance equality and normal 155 
distribution, respectively. Conventional one-way ANOVA followed by the Bonferroni post hoc 156 
significance test was applied when normal distribution and equality of variance existed. Otherwise, 157 
non-parametric tests (Kruskal-Wallis and Mann-Whitney U rank-sum tests) were used to assess 158 
significance. Statistical analysis was performed using the software package SPSS 22.0 (SPSS, Inc. 159 
USA) and significant differences were established at P<0.05. 160 
Results 161 
Body weight and chow intake 162 
Throughout the study no changes in the increasing body weight pattern were found as a result of CF 163 
and I diet intake. However, the cocoa-fed animals showed a slower body weight increase, this being 164 
significantly lower in comparison to that of the rest of the groups throughout the study (up to 31.7% 165 
lower body weight increase in the C10 group compared to the rest of the groups at day 7, 72.2% at 166 
day 14 and 103.2% at day 21). This effect was not related to lower chow intake, which was similar 167 
throughout the study in all experimental groups (data not shown). Similar results on body weight by 168 
10% cocoa diet have been already reported(13,15,18). 169 
Immunoglobulin content in the inductor intestinal compartments 170 
After three weeks of nutritional intervention, changes in IgA and IgM concentrations in both 171 
studied inductor compartments in the intestine (PP and MLN) were observed (Fig. 1). In PP, the 172 
C10 diet significantly reduced the IgA and IgM concentrations (Fig. 1(a) and (b)) compared to those 173 
observed in the rest of the groups (P<0.05), whereas the CF increased the IgM concentration with 174 
respect to the I-fed animals (P<0.05). The I diet did not significantly modify the IgA and IgM 175 
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concentration in PP. The same changes on PP IgA and IgM concentrations were already observable 176 
after just one week of nutritional intervention with the C10 diet (P<0.05) (online Supplementary 177 
Table S1). 178 
Fig. 1. Effects of cocoa diet on IgA and IgM content in the inductor intestinal compartments 
after three weeks of diets. IgA (a) and IgM (b) concentration in Peyer’s patches, and IgA (c) 
and IgM (d) concentration in mesenteric lymph nodes. Values are mean (n 10) with their 
standard errors represented by vertical bars. *Mean value was significantly different from that 
of the reference (REF) group (P<0.05); †Mean value was significantly different from that of 
the group consuming the cocoa diet (C10) (P<0.05); ‡Mean value was significantly different 
from that of the group consuming the cocoa fibre diet (CF) (P<0.05); §Mean value was 













































































































































In MLN, the C10 intake did not significantly modify IgA concentration (Fig. 1(c)) but resulted in a 180 
significant IgM reduction in comparison with those in the REF, CF and I groups (P<0.05) (Fig. 181 
1(d)). No statistical differences on MLN IgM or IgA were observed after just one week of C10 diet 182 
(online Supplementary Table S1). Moreover, in the same tissue the CF diet increased the IgA 183 
concentration compared to the other groups (P<0.05) and also the IgM concentration compared to 184 
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the I group (P<0.05) (Fig. 1(c) and (d)). This increase in MLN IgA and IgM was already observed 185 
after one week of diet (online Supplementary Table S1). The I diet did not significantly modify the 186 
IgA and IgM concentration in MLN (Fig. 1(c) and (d)). 187 
Immunoglobulin content in the effector intestinal compartments  188 
IgA and IgM concentrations were also determined in GW as representative of the production of Ig 189 
in the effector tissues (Fig. 2). Although all three experimental diets significantly reduced the GW 190 
IgA concentration compared to the REF group (P<0.05), it was the C10 diet that produced the most 191 
profound reduction in comparison with the CF and I diets (P<0.05) (Fig. 2(a)) that was already 192 
observed after one week of nutritional intervention (P<0.05) (online Supplementary Table S1). The 193 
decrease in IgA after the I diet intake was also more pronounced than that observed in the CF group 194 
(P<0.05). With regards to the IgM in GW, the C10 diet reduced its concentration compared to the 195 
rest of the groups (P<0.05) (Fig. 2(b)). The CF diet increased the IgM concentration compared to 196 
that produced by the I diet (P<0.05), but not when compared to the REF diet. 197 
 198 
Fig. 2. Effects of cocoa diet on IgA and IgM content in the effector intestinal compartments after 
three weeks of diets. IgA (a) and IgM (b) concentration in gut washes. Values are mean (n 10) with 
their standard errors represented by vertical bars. *Mean value was significantly different from that 
of the reference (REF) group (P<0.05); ‡Mean value was significantly different from that of the 
group consuming the cocoa fibre diet (CF) (P<0.05); §Mean value was significantly different from 

































































Immunoglobulin content in the effector extra-intestinal mucosal compartments 200 
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Regarding the salivary glands, a similar pattern was observed in the SMG and PSG for both Ig 201 
(Fig. 3). The C10 diet significantly reduced the IgA and IgM content in both salivary glands 202 
compared to the rest of the diets (P<0.05). The CF diet also reduced IgA concentration in both 203 
salivary glands in a more modest way in comparison to the REF diet (Fig. 3(a) and (c)), without 204 
affecting the IgM concentration (Fig. 3(b) and (d)). The same C10 and CF effects were already 205 
observed after one week (online Supplementary Table S1). No changes in IgA and IgM were 206 
observed in the salivary glands after I diet intake.  207 
 208 
Fig. 3. Effects of cocoa diet on IgA and IgM content in the effector extra-intestinal mucosal 
compartments after three weeks of diets. IgA (a) and IgM (b) concentration in the submaxillary 
gland and IgA (c) and IgM (d) concentration in the parotid gland. Values are mean (n 10) with 
their standard errors represented by vertical bars. *Mean value was significantly different from that 
of the reference (REF) group (P<0.05); ‡Mean value was significantly different from that of the 
group consuming the cocoa fibre diet (CF) (P<0.05); §Mean value was significantly different from 






































































































































































Systemic immunoglobulins 210 
Serum concentrations of IgA, IgM and IgG from all experimental groups after three weeks of diet 211 
are summarized in Fig. 4. With regards to the IgA concentration, the CF diet intake resulted in 212 
higher levels of IgA compared to the rest of the diets (P<0.05) (Fig. 4(a)). IgM concentration was 213 
reduced by the C10 diet when compared to the REF diet after 3 weeks of intervention (P<0.05) 214 
(Fig. 4(b)). Serum IgG concentration was diminished by both the C10 and CF diets compared to the 215 
REF diet at the end of the third week of study (P<0.05) (Fig. 4(c)).  216 
 217 
Fig. 4. Effects of cocoa diet on serum IgA (a), IgM (b) and IgG (c) concentrations after three weeks 
of diets. Values are mean (n 10) with their standard errors represented by vertical bars. *Mean value 
was significantly different from that of the reference (REF) group (P<0.05); ‡Mean value was 
significantly different from that of the group consuming the cocoa fibre diet (CF) (P<0.05); §Mean 








































































Submaxillary gland gene expression 218 
Gene expression of IgA, CCL28, TGF-β1, RARα, RARβ, pIgR and IL-6 was assessed in the SMG 219 
at the end of the study to examine in depth the mechanism involved in the Ig modulation activity of 220 
cocoa products (Fig. 5). The IgA expression was significantly down-regulated only in the C10 221 
group compared to the REF and CF diets, whereas CCL28 was significantly up-regulated by this 222 
diet compared to the CF diet (P<0.05). In addition, a tendency to down-regulate the TGF-β1 gene 223 
expression has been observed in the C10 diet. On the other hand, the CF diet fed animals showed 224 
significantly lower expression of TGF-β1 and RARα after three weeks of nutritional intervention 225 
compared to the REF animals (P<0.05). Moreover, the expression of pIgR in those animals fed with 226 
CF was also significantly lower than those fed with I diet (P<0.05). The I diet did not modify the 227 
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expression of any of the studied genes. The Il6 expression was not detected in the SMG from any of 228 
the studied groups.  229 
 230 
Fig. 5. Expression of genes associated with IgA synthesis, secretion, switching, intestinal homing 
in submaxillary salivary gland after three weeks of diets. Expression levels were normalized using 
the expression of Gusb as the endogenous housekeeping gene. Values are mean (n 5-6) with their 
standard errors represented by vertical bars. *Mean value was significantly different from that of 
the reference (REF) group, which represents 100% gene expression (P<0.05); ‡Mean value was 
significantly different from that of the group consuming the cocoa fibre diet (CF) (P<0.05); §Mean 




































In previous studies, we reported that the intake of a 10% cocoa diet down-regulates the Ig content at 233 
systemic and intestinal levels in young rats(13–16). However, the impact of cocoa at the 234 
extra-intestinal mucosal level, the mechanism by which it may act and the involvement of cocoa 235 
fibre in such effects are unknown to date. This study compares the effect of the whole cocoa intake 236 
with that produced by cocoa fibre extract (with a lower amount of polyphenols) on Ig production 237 
and that produced by a soluble fibre such as inulin. The results showed that the diet containing 238 
whole cocoa (C10 diet) induced the most pronounced effects on the synthesis of Ig in intestinal and 239 
extra-intestinal mucosal compartments. In addition, we found that most of the cocoa effects 240 
observed at the end of the third week were already significant after just one week of the diet. The 241 
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impact of the cocoa fibre on Ig production was lower than that produced by the whole cocoa in 242 
some tissues (GW and salivary glands for IgA) whereas in other compartments it had no effect (PP 243 
for both Ig and GW, MLN and serum for IgM) or it even exerted the opposite effect (MLN and 244 
serum for IgA). Finally, the soluble fibre-enriched diet only modified the GW IgA levels, 245 
decreasing its concentration, similar to those effects resulting from CF intake. The consequence and 246 
meaning of these results in each compartment are discussed next. 247 
At the GALT inductor sites (PP and MLN), cocoa intake attenuated the production of the IgM 248 
synthesis in MLN and that of IgA and IgM in PP after three weeks of diet, the latter effects already 249 
being observed after one week of the diet. On the contrary, the CF diet (containing a very low 250 
amount of polyphenols) exerted the opposite effect of the C10 diet by increasing the IgA content in 251 
both PP and MLN (only significant in the latter). These results are in line with those previously 252 
reporting a higher proportion of IgA-coated bacteria in faeces from the CF-fed animals(19). To our 253 
knowledge, this is the first report about the immune-potentiating effect of cocoa fibre. In line with 254 
these results, a rise in the IgA concentration has also been described for well-known substances 255 
with prebiotic effects(21). Contrary to that, the prebiotic substance used in the present study (inulin) 256 
did not modulate Ig production, as reported in other studies(22), which could be attributed to several 257 
factors, such as the methodologies, population groups, length of intervention, as well as the type 258 
and dose of inulin used(23). Likewise, the CF diet increased the IgM content in PP and MLN with 259 
respect to the I group, suggesting that cocoa fibre has particular compounds and/or composition that 260 
are not in common with inulin, which could contribute to these effects. In addition, it is possible 261 
that the prebiotic effects attributed to the cocoa fibre(19) may be involved in the mechanism by 262 
which cocoa fibre increased the IgA concentration in this compartment. This enhancement is also 263 
reflected in serum from the CF group, in which IgA concentration is also increased, behaviour that 264 
is not always present after prebiotic intake(24,25). Moreover, this means that the fibre present in 265 
cocoa can be discarded as being the main factor responsible for the down-regulation caused by the 266 
whole cocoa, and this allows us to suggest that other compounds present in cocoa may be masking 267 
and counteracting the immune-potentiating effect of the cocoa fibre.  268 
Regarding the effector intestinal compartment (GW), previous studies carried out in our laboratory 269 
reported a reduction in IgA and IgM concentration after a six-week cocoa diet(15). In line with those 270 
results, in the present study we have observed that this reductive effect of cocoa is already 271 
evidenced after three weeks and one week of diet, thus showing the early down-regulatory effects of 272 
cocoa. The cocoa fibre- or inulin-fed animals also presented lower IgA concentration in this 273 
14 
 
compartment. Therefore, the CF effect on inductor sites is not reproduced at effector level. 274 
However, as the CF influence was not as pronounced as that produced by the whole cocoa diet, 275 
cocoa fibre might only be partially contributing to the down-regulatory effects of cocoa and other 276 
cocoa compounds, such as flavonoids, might be potentiating the effect of fibre, or even be the key 277 
factor responsible for this effect. Nonetheless, studies using three different polyphenol-enriched 278 
cocoa extracts evidenced that although they were also able to modulate the Ig production, they were 279 
not the main compound in charge of  such an effect(18,26). Therefore, further studies should be 280 
carried out in order to fully elucidate the contribution of other cocoa components, such as 281 
methylxanthines on these intestinal effects.  282 
A third compartment included in the current study was the salivary glands. Despite the existing 283 
evidence about the protective effect of flavonoid consumption from medication and/or age-related 284 
dysfunction of salivary glands(27–29), there is no information about the impact of polyphenols on the 285 
salivary glands’ Ig production. In fact, to our knowledge, this is the first report describing the 286 
impact of whole cocoa (containing polyphenols and fibre) on Ig production in the extra-intestinal 287 
mucosal compartments. We observed that the C10 diet diminished the IgA and IgM concentrations 288 
in the salivary glands at the end of just one week of dietary intervention. Similarly, there is scarce 289 
information about the influence of indigestible carbohydrates on IgA response in the salivary 290 
glands, this being the first time the impact of fibre from cocoa or as inulin on the Ig production in 291 
these tissues has been described. Here we have reported that the CF-fed animals, although in a more 292 
moderate way than the C10 group, also presented lower concentrations of IgA in this compartment 293 
at the same time points. These results are not in line with those observed in animals fed with 294 
fructooligosaccharide (FOS) and a mixture of polydextrose and lactitol which induced higher 295 
submandibular IgA concentration(25). Unlike the prebiotic substances and the results mentioned 296 
above, the cocoa fibre did not exert immune-potentiating effects in the salivary glands, thus 297 
suggesting that not only the fibre but also other compounds present in cocoa might be interfering 298 
with the Ig production in the salivary glands. 299 
In order to obtain insights into the underlying mechanism associated with the reduction in IgA 300 
concentration in the salivary glands due to the diets, the gene expression of some key molecules 301 
involved in IgA synthesis and regulation, as well as IgA-SCs mucosal homing has been evaluated in 302 
this compartment. Here, we have observed that the IgA gene expression was drastically 303 
down-regulated by the C10 group but not by the CF and I groups. This result agrees with the most 304 
pronounced effects of the C10 diet on SMG IgA content, which could be due to the presence of a 305 
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lower number of IgA-SCs cells in this tissue and/or a lower ability to secrete it. Some of the 306 
molecules involved in the maturation and differentiation of B cells in becoming IgA-SCs are IL-6 307 
and TGF-β1. Although IL-6 mRNA was not detected in the SMG, the TGF-β1 gene expression 308 
tended to be lessened by all three experimental diets, only being statistically significant in the CF 309 
diet. These results suggest the attenuating effect of soluble fibre in the differentiation of B cells into 310 
the salivary glands, and could partially explain the decreased IgA content found after the C10 and 311 
CF diets. Similar results have been found in the small intestine from animals fed with a cocoa diet 312 
for three and seven weeks(15,30).  313 
Once the IgA-secreting B cells are activated, they migrate to the blood and later return to the 314 
mucosal effector compartments(5). Mucosal homing is mainly regulated by adhesion molecules and 315 
chemokine-mediated interaction. To date, CCL28 chemokine and its corresponding receptor are 316 
crucial in the recruitment of IgA+ B cells to the extra-intestinal as well as intestinal mucosa(31,32). 317 
Here, similarly to what has been reported in the small intestine(30), the C10 intake, but not the CF, 318 
up-regulated the expression of CCL28. These results may point to a compensatory mechanism to 319 
strongly attract the IgA+ B cells to avoid the down-modulation on IgA concentration. Other 320 
molecules involved in the intestinal cell homing mechanism are those that constitute the retinoic 321 
acid nuclear receptor family (RAR)(33). After evaluating the expression of both RARα and RARβ in 322 
the salivary gland we found that the C10 intake for three weeks did not modify either the expression 323 
of RARα or RARβ at this level, which agrees with those results obtained in the small intestine and 324 
MLN after three weeks of diet(15). However, the CF diet significantly reduced the expression of 325 
RARα but not RARβ, which could contribute to the IgA-decreasing effect of the CF on salivary 326 
glands. Finally, in order to reach the mucosal lumen, the IgA requires the association with the 327 
transmembrane epithelial protein pIgR(4). We found that pIgR gene expression was not modified by 328 
the C10 diet at the extra-intestinal level or in the intestine(15), thus indicating that the reduction of 329 
IgA concentration associated with the cocoa intake is not due to a lower transport across the 330 
epithelium. Little is known about the impact of fibre on the pIgR gene expression. To date, an 331 
increase in its expression after the intake of FOS and a mixture of polydextrose and lactitol in 332 
rodents has been reported(25,34). However, in the present study the CF intake resulted in a lower 333 
pIgR gene expression, suggesting that the reduction on IgA content in the salivary glands as a result 334 
of cocoa fibre intake also takes place by means of IgA transport.  335 
In summary, we have demonstrated that a cocoa diet led to a lower IgA and IgM secretion in both 336 
inductor and effector intestinal compartments as well as in the extra-intestinal mucosal 337 
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compartment in young Wistar rats. Most of these effects could be already observed after one week 338 
of nutritional intervention. Soluble fibre seems to be partially responsible for the lower IgA 339 
secretion into the intestinal lumen. In spite of the results produced by the cocoa diet, it is worth 340 
noting that the enhancement by the CF diet of the IgA synthesis in the inductor intestinal 341 
compartment was also detectable at the systemic level, where higher IgA concentration was 342 
quantified. Both the C10 and CF diets produced a down-regulatory effect on the IgA secretion in 343 
the extra-intestinal tissues. The C10 diet interacted with the mechanisms involved in the IgA 344 
synthesis in a similar way to that observed in the small intestine, whereas the cocoa fibre showed 345 
particular effects on homing and transcytosis of IgA across the epithelial gland.  346 
Overall, cocoa fibre has IgA immune-potentiating effects that are counteracted when it is present in 347 
the whole cocoa product. This fact suggests that other cocoa components are involved in such an 348 
effect. This immunomodulation is not found in the inulin diet. Further studies must be considered to 349 
ascertain the mechanism by which cocoa fibre is able to act in up-regulating the IgA production at 350 
the intestinal inductor compartments whereas it down-regulates its production in those of the 351 
mucosal effectors. 352 
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